Clinical Trials Directory

Trials / Unknown

UnknownNCT05855356

Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial

The Long-CoviD Patients Causal Diagnosis and Rehabilitation Randomized Feasibility Controlled Trial in Patients With Dysautonomia: the LoCoDiRe-Dys Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Evangelismos Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Dysautonomia in post-covid-19 condition appears to affect a significant number of patients, with reports raising the incidence up to 61%, having an overlap with myalgic encephalomyelitis/ chronic fatigue syndrome. Quality of life and daily function is significantly impacted and conservative management interventions, despite the lack of high quality evidence up to now, are needed to ameliorate disability. 50 adults with a dysautonomia post-covid-19 diagnosis based on the Ewing battery and a NASA lean test will be enrolled in a randomized single blinded controlled trial with a crossover design. Feasibility and lack of definite dysautonomia diagnosis will be the primary out-comes, while secondary outcomes will be health-related, clinical and cardiopulmonary exercise test indicators. Safety and acceptance will also be checked, primarily excluding participants with post exertional malaise. The Long-CoViD patients Causal Diagnosis and Rehabilitation study in patients with Dysautonomia (LoCoDiRE-Dys) study intervention will consist of an educational module, breathing retraining and an individualized exercise intervention of biweekly sessions for two months with regular assessment of both groups. LoCoDiRe- Dys aims to be the first post-covid-19 randomized study in people with dysautonomia offering a multimodal intervention both in diagnosis and management

Conditions

Interventions

TypeNameDescription
PROCEDURERehabilitationrespiratory physiotherapy, personalized aerobic and strength training
PROCEDUREStandard of CareBehavioural and Medical management

Timeline

Start date
2023-02-01
Primary completion
2023-12-30
Completion
2024-03-27
First posted
2023-05-11
Last updated
2023-05-11

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05855356. Inclusion in this directory is not an endorsement.

Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial (NCT05855356) · Clinical Trials Directory